# SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women

> **NCT01185782** · PHASE3 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 300 (actual)

## Conditions studied

- Infertility
- Ovulation Induction

## Interventions

- **DRUG:** Gonalef® (Follitropin alfa)
- **DRUG:** Purified pituitary gonadotropin (Fertinorm-P®)

## Key facts

- **NCT ID:** NCT01185782
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2013-12-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01185782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01185782, "SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01185782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*